Mr. Wilkinson has accepted the position of president and CEO at Impax Laboratories. He was appointed president of Actavis Global R&D in January.
Actavis develops and manufactures pharmaceutical products. The company’s North American branded pharmaceuticals business is focused primarily on women’s health, urology, gastroenterology and dermatology.
More Articles on Gastroenterology:
9 Statistics on Gastroenterologist Compensation by Location
AGA Calls for More Transparency From CMS
The Growing Role of Biologics in Gastroenterology
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
